Sanofi-Aventis Awards Euro RSCG Worldwide Drug Account

  • November 17, 2006
Sanofi-Aventis, the world's third-largest pharmaceutical company, has named Euro RSCG Worldwide its global agency in charge of all communications for Lovenox/Clexane, a leading product for thrombosis treatment, and Lantus and Apidra, which treat diabetes. This is the first global pharmaceutical client for the company. Sanofi-Aventis has enlarged its partnership with Euro RSCG Life by awarding the agency the responsibility of launching all communications programs for all new brands in these two therapeutic domains.

Next story loading loading..